Explore the future of ocular gene editing and strategic drug delivery at SMi’s Ophthalmic Drugs 2018
LONDON, UNITED KINGDOM, June 7, 2018 /EINPresswire.com/ -- SMi Group are delighted to welcome the expertise from a senior panel of big pharma and ophthalmic organisations, as well as regulatory bodies, at the 2nd annual Ophthalmic Drugs 2018 conference, …